Suppr超能文献

ANGPTL8 和抵抗素与 2 型糖尿病糖尿病肾病的关系。

Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus.

机构信息

Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Wuhan Branch of National Clinical Research Center for Metabolic Diseases, Wuhan, China.

出版信息

Front Endocrinol (Lausanne). 2021 Sep 15;12:695750. doi: 10.3389/fendo.2021.695750. eCollection 2021.

Abstract

BACKGROUND

Previous studies showed altered angiopoietin-like protein-8 (ANGPTL-8) and resistin circulating levels in type 2 diabetes mellitus (T2DM). Whether or not the alteration in ANGPTL-8 and resistin level can be a predictive maker for increased diabetic nephropathy risk remains unclear.

AIM

To Investigate the possible association of ANGPTL-8 and resistin with DN, and whether this association is affected by NAFLD status.

METHODS

A total of 278 T2DM patients were enrolled. Serum levels of ANGPTL8, resistin, BMI, blood pressure, duration of diabetes, glycosylated hemoglobin (HbA1c), fasting blood glucose (FPG), hypersensitive C-reactive protein (hs-CRP), lipid profile, liver, and kidney function tests were assessed. The relationship between DN with ANGPTL8 and resistin was analyzed in the unadjusted and multiple-adjusted regression models.

RESULTS

Serum levels of ANGPTL8 and resistin were significantly higher in DN compared with T2DM subjects without DN (respectively; P <0.001), especially in non-NAFLD populations. ANGPTL8 and resistin showed positive correlation with hs-CRP (respectively; <0.01), and negative correlation with estimated GFR (eGFR) (respectively; =<0.001) but no significant correlation to HOMA-IR(respectively; P>0.05). Analysis showed ANGPTL8 levels were positively associated with resistin but only in T2DM patients with DN(r=0.1867; <0.05), and this significant correlation disappeared in T2DM patients without DN. After adjusting for confounding factors, both ANGPTL8(OR=2.095, 95%CI 1.253-3.502 P=0.005) and resistin (OR=2.499, 95%CI 1.484-4.208 P=0.001) were risk factors for DN. Data in non-NAFLD population increased the relationship between ANGPTL8 (OR=2.713, 95% CI 1.494-4.926 P=0.001), resistin (OR=4.248, 95% CI 2.260-7.987 P<0.001)and DN. The area under the curve (AUC) on receiver operating characteristic (ROC) analysis of the combination of ANGPTL8 and resistin was 0.703, and the specificity was 70.4%. These data were also increased in non-NAFLD population, as the AUC (95%CI) was 0.756, and the specificity was 91.2%.

CONCLUSION

This study highlights a close association between ANGPTL8, resistin and DN, especially in non-NAFLD populations. These results suggest that ANGPTL-8 and resistin may be risk predictors of DN.

摘要

背景

先前的研究表明,2 型糖尿病(T2DM)患者的血管生成素样蛋白 8(ANGPTL-8)和抵抗素循环水平发生了改变。ANGPTL-8 和抵抗素水平的改变是否可以作为糖尿病肾病(DN)风险增加的预测标志物尚不清楚。

目的

研究 ANGPTL-8 和抵抗素与 DN 的可能相关性,以及这种相关性是否受非酒精性脂肪性肝病(NAFLD)状态的影响。

方法

共纳入 278 例 T2DM 患者。评估血清 ANGPTL8、抵抗素、体重指数(BMI)、血压、糖尿病病程、糖化血红蛋白(HbA1c)、空腹血糖(FPG)、超敏 C 反应蛋白(hs-CRP)、血脂谱、肝肾功能检查。在未调整和多因素调整的回归模型中分析 DN 与 ANGPTL8 和抵抗素的关系。

结果

与无 DN 的 T2DM 患者相比,DN 患者的血清 ANGPTL8 和抵抗素水平明显升高(分别为;P<0.001),尤其是在非 NAFLD 人群中。ANGPTL8 和抵抗素与 hs-CRP 呈正相关(分别为;<0.01),与估计肾小球滤过率(eGFR)呈负相关(分别为;<0.001),但与 HOMA-IR 无显著相关性(分别为;P>0.05)。分析表明,ANGPTL8 水平与抵抗素呈正相关,但仅在 T2DM 合并 DN 患者中具有统计学意义(r=0.1867;<0.05),而在 T2DM 不合并 DN 患者中则无显著相关性。在调整混杂因素后,ANGPTL8(OR=2.095,95%CI 1.253-3.502,P=0.005)和抵抗素(OR=2.499,95%CI 1.484-4.208,P=0.001)均为 DN 的危险因素。非 NAFLD 人群的数据增加了 ANGPTL8(OR=2.713,95%CI 1.494-4.926,P=0.001)、抵抗素(OR=4.248,95%CI 2.260-7.987,P<0.001)与 DN 之间的关系。受试者工作特征(ROC)分析中 ANGPTL8 和抵抗素联合的曲线下面积(AUC)为 0.703,特异性为 70.4%。这些数据在非 NAFLD 人群中也有所增加,AUC(95%CI)为 0.756,特异性为 91.2%。

结论

本研究强调了 ANGPTL8、抵抗素与 DN 之间的密切关联,尤其是在非 NAFLD 人群中。这些结果表明,ANGPTL-8 和抵抗素可能是 DN 的风险预测因子。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验